BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 30053340)

  • 1. Delimiting the autoinhibitory module of von Willebrand factor.
    Deng W; Voos KM; Colucci JK; Legan ER; Ortlund EA; Lollar P; Li R
    J Thromb Haemost; 2018 Oct; 16(10):2097-2105. PubMed ID: 30053340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A discontinuous autoinhibitory module masks the A1 domain of von Willebrand factor.
    Deng W; Wang Y; Druzak SA; Healey JF; Syed AK; Lollar P; Li R
    J Thromb Haemost; 2017 Sep; 15(9):1867-1877. PubMed ID: 28692141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Desialylation of O-glycans activates von Willebrand factor by destabilizing its autoinhibitory module.
    Voos KM; Cao W; Arce NA; Legan ER; Wang Y; Shajahan A; Azadi P; Lollar P; Zhang XF; Li R
    J Thromb Haemost; 2022 Jan; 20(1):196-207. PubMed ID: 34529349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific electrostatic interactions between charged amino acid residues regulate binding of von Willebrand factor to blood platelets.
    Interlandi G; Yakovenko O; Tu AY; Harris J; Le J; Chen J; López JA; Thomas WE
    J Biol Chem; 2017 Nov; 292(45):18608-18617. PubMed ID: 28924049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoinhibitory module underlies species difference in shear activation of von Willebrand factor.
    Arce NA; Liu Y; Chen W; Zhang XF; Li R
    J Thromb Haemost; 2022 Nov; 20(11):2686-2696. PubMed ID: 36031939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of von Willebrand factor domain A1 with platelet glycoprotein Ibalpha-(1-289). Slow intrinsic binding kinetics mediate rapid platelet adhesion.
    Miura S; Li CQ; Cao Z; Wang H; Wardell MR; Sadler JE
    J Biol Chem; 2000 Mar; 275(11):7539-46. PubMed ID: 10713059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The N-terminal flanking region of the A1 domain regulates the force-dependent binding of von Willebrand factor to platelet glycoprotein Ibα.
    Ju L; Dong JF; Cruz MA; Zhu C
    J Biol Chem; 2013 Nov; 288(45):32289-32301. PubMed ID: 24062306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Purified A2 domain of von Willebrand factor binds to the active conformation of von Willebrand factor and blocks the interaction with platelet glycoprotein Ibalpha.
    Martin C; Morales LD; Cruz MA
    J Thromb Haemost; 2007 Jul; 5(7):1363-70. PubMed ID: 17389010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet GpIba binding to von Willebrand Factor under fluid shear:contributions of the D′D3-domain, A1-domain flanking peptide and O-linked glycans.
    Madabhushi SR; Zhang C; Kelkar A; Dayananda KM; Neelamegham S
    J Am Heart Assoc; 2014 Oct; 3(5):e001420. PubMed ID: 25341886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a novel 14-3-3zeta binding site within the cytoplasmic domain of platelet glycoprotein Ibalpha that plays a key role in regulating the von Willebrand factor binding function of glycoprotein Ib-IX.
    Yuan Y; Zhang W; Yan R; Liao Y; Zhao L; Ruan C; Du X; Dai K
    Circ Res; 2009 Dec; 105(12):1177-85. PubMed ID: 19875727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The soluble N-terminal autoinhibitory module of the A1 domain in von Willebrand factor partially suppresses its catch bond with glycoprotein Ibα in a sandwich complex.
    Zhao YC; Li Z; Ju LA
    Phys Chem Chem Phys; 2022 Jun; 24(24):14857-14865. PubMed ID: 35698887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure and function of the von Willebrand factor A1 domain: analysis with monoclonal antibodies reveals distinct binding sites involved in recognition of the platelet membrane glycoprotein Ib-IX-V complex and ristocetin-dependent activation.
    De Luca M; Facey DA; Favaloro EJ; Hertzberg MS; Whisstock JC; McNally T; Andrews RK; Berndt MC
    Blood; 2000 Jan; 95(1):164-72. PubMed ID: 10607699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modeling and functional analysis of the interaction between von Willebrand factor A1 domain and glycoprotein Ibalpha.
    Vasudevan S; Roberts JR; McClintock RA; Dent JA; Celikel R; Ware J; Varughese KI; Ruggeri ZM
    J Biol Chem; 2000 Apr; 275(17):12763-8. PubMed ID: 10777573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conformational changes in the A3 domain of von Willebrand factor modulate the interaction of the A1 domain with platelet glycoprotein Ib.
    Obert B; Houllier A; Meyer D; Girma JP
    Blood; 1999 Mar; 93(6):1959-68. PubMed ID: 10068669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A biophysical view on von Willebrand factor activation.
    Löf A; Müller JP; Brehm MA
    J Cell Physiol; 2018 Feb; 233(2):799-810. PubMed ID: 28256724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The linker between the D3 and A1 domains of vWF suppresses A1-GPIbα catch bonds by site-specific binding to the A1 domain.
    Tischer A; Cruz MA; Auton M
    Protein Sci; 2013 Aug; 22(8):1049-59. PubMed ID: 23775931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinetics of GPIbalpha-vWF-A1 tether bond under flow: effect of GPIbalpha mutations on the association and dissociation rates.
    Kumar RA; Dong JF; Thaggard JA; Cruz MA; López JA; McIntire LV
    Biophys J; 2003 Dec; 85(6):4099-109. PubMed ID: 14645097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-Based Cyclic Glycoprotein Ibα-Derived Peptides Interfering with von Willebrand Factor-Binding, Affecting Platelet Aggregation under Shear.
    Hrdinova J; Fernández DI; Ercig B; Tullemans BME; Suylen DPL; Agten SM; Jurk K; Hackeng TM; Vanhoorelbeke K; Voorberg J; Reutelingsperger CPM; Wichapong K; Heemskerk JWM; Nicolaes GAF
    Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Shielding the front-strand beta 3 of the von Willebrand factor A1 domain inhibits its binding to platelet glycoprotein Ibalpha.
    Bonnefoy A; Yamamoto H; Thys C; Kito M; Vermylen J; Hoylaerts MF
    Blood; 2003 Feb; 101(4):1375-83. PubMed ID: 12393553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycosylation sterically inhibits platelet adhesion to von Willebrand factor without altering intrinsic conformational dynamics.
    Tischer A; Machha VR; Moon-Tasson L; Benson LM; Auton M
    J Thromb Haemost; 2020 Jan; 18(1):79-90. PubMed ID: 31479573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.